Communiqués Edwards Lifesciences Corporation

Actions

EW

US28176E1082

Equipement et technologie médicale avancés

Marché Fermé - NYSE 22:00:02 27/08/2026			Varia. 5j.	Varia. 1 janv.
89,95 ^USD	-0,91 %		-2,52 %	+5,51 %

27/08	Edwards Lifesciences : cession d'actions pour 2 894 440 $ par un dirigeant, selon un document de la SEC	MT
21/08	Edwards Lifesciences Corporation : Argus reste à l'achat	ZM

Communiqués

25/08	Do I Really Need To File? HSR Avoidance And The Edwards/Genesis Settlement (Podcast)	AQ
05/08	FTC Reaches $12 Million Settlement Over Alleged HSR Act Violations	AQ
05/08	Edwards Lifesciences : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)	PU
24/07	Substance Over Form: The FTC’s $12 Million HSR Evasion Penalty And What It Signals For Dealmakers	AQ
24/07	FTC Secures $12 Million In Penalties For Alleged HSR Violation	AQ
23/07	Edwards Lifesciences Reports Second Quarter Results	BU
17/07	FTC And DOJ Secure $12 Million Settlement For HSR Act Violations In Edwards/JC Medical Deal	AQ
16/07	Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026	BU
03/07	Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?	PR
26/06	Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves	BU
12/06	Annual Checkup From The ABA Antitrust In Healthcare Conference	AQ
04/05	Edwards Lifesciences Announces Appointment of CFO	BU
02/05	Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue	BU
28/04	Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference	BU
23/04	Edwards Lifesciences Reports First Quarter Results	BU
16/04	Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026	BU
30/03	Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits	BU
26/02	Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose	BU
19/02	Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences	BU
16/02	Achy Breaky Heart: The FTC Blocks Edwards-JenaValve Aortic Device Deal	AQ
13/02	Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day	BU
10/02	Edwards Lifesciences Reports Fourth Quarter Results	BU
09/02	FTC Win Clarifies Antitrust Enforcement In Development Pipeline Deals	AQ
05/02	Seal The Valve, But Not The Deal: Court Blocks Edwards Lifesciences' Pre Commercial Merger	AQ
03/02	Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026	BU